Ukusetshenziswa kwe-opioid ngeziguli ezibuhlungu ezingapheli kungase kwehle noma kuzinzile ngemva kokuthola idivayisi yokuvuselela intambo yomgogodla, ngokusho kocwaningo olusha.
Imiphumela yenza abacwaningi basikisele ukuthi odokotela bacabangele ukukhuthazwa kwentambo yomgogodla (SCS) ngokushesha ezigulini ezibuhlungu kakhulu ngokuhamba kwesikhathi kunokuba zinikeze ama-painkillers amaningi, kusho umcwaningi oyinhloko u-Ashwini Sharan, MD, engxoxweni.Ama-transmitters amancane, anamandla ebhethri aletha amasignali ngemikhondo kagesi efakwe eduze komgogodla ukuze aphazamise imilayezo yobuhlungu esuka ezinzwa iya ebuchosheni.
Ucwaningo lwaluhlanganisa idatha yomshuwalense evela ezigulini ze-5476 ezazine-SCS futhi ziqhathanisa izinombolo zemiyalelo yazo ye-opioid ngaphambi nangemva kokufakwa.Ngonyaka owodwa ngemva kokufakelwa, i-93% yeziguli ezaqhubeka nokwelashwa komgogodla (SCS) zinezilinganiso eziphansi ezilinganayo ze-morphine-equivalent nsuku zonke kuneziguli ezazinesistimu yazo ye-SCS isusiwe, ngokocwaningo, uSharan ahlela ukuyihambisa ukuze ishicilelwe.
"Esikuqaphelile ukuthi abantu babe nokukhuphuka okukhulu ekusebenziseni kwabo izidakamizwa ngonyaka ngaphambi kokufakelwa," kusho uSharan, uprofesa we-neurosurgery e-Thomas Jefferson University e-Philadelphia kanye nomongameli weNorth American Neuromodulation Society.USharan wethule imiphumela emhlanganweni waminyaka yonke weqembu kuleli sonto.” Eqenjini elaqhubeka ne-SCS, umthamo wezidakamizwa wehliswa futhi waba izinga owawukulo ngaphambi kokuba unyuke.
"Ayikho imininingwane eminingi emihle yabantu, ngokuyisisekelo, eshoyo ukuthi buyini ubudlelwano phakathi kwalezi zidakamizwa kanye nalezi zimila. Lokho empeleni kuwumgomo walokhu," wengeza. "Sinombhalo osebenzayo kanye nephrothokholi futhi sixhasa ucwaningo oluzayo. yokusebenzisa idivayisi njengesu lokunciphisa i-narcotic ngoba ukholelwa noma cha, lokho akuzange kufundwe."
Abacwaningi bebengazi ukuthi yiziphi izinhlelo ze-SCS zabakhiqizi ezafakwa ezigulini ezazifunda imininingwane yazo, futhi azinalo uxhaso oluhlelelwe olunye ucwaningo, ngokusho kukaSharan.Ucwaningo lokuqala lwaluxhaswe yi-St. Jude Medical, esanda kutholwa ngu-Abbott.I-FDA igunyaze isistimu ye-St. Jude's BurstDR SCS ngo-Okthoba odlule, okwakamuva ochungechungeni lokugunyazwa kwe-SCS.
U-Abbott wenza umzamo omkhulu wokunxenxa odokotela ukuthi banikeze isibulali-zinhlungu se-opioid i-OxyContin eminyakeni yokuqala yokutholakala kwayo, ngokombiko we-STAT News.Inhlangano yezindaba ithole amarekhodi ecaleni elethwe yisifunda sase-West Virginia ngokumelene no-Abbott kanye nonjiniyela we-OxyContin u-Purdue Pharma LP, izinsolo zokuthi bamakethe umuthi ngokungafanele.U-Purdue wakhokha u-$10 million ngo-2004 ukuze axazulule leli cala.Ayikho inkampani, ebivumile ukuphromotha i-OxyContin, evumile ukwenza okubi.
"I-SCS iyindlela yokugcina," kuqhubeka uSharan."Uma ulinda unyaka ukuthi umuntu acishe aphinde kabili umthamo wakhe wezidakamizwa, kufanele umkhiphe kulokho. Isikhathi esiningi esilahlekile."
Imithi kadokotela yonyaka ye-morphine ngokuvamile ibiza u-$5,000, futhi izindleko zemiphumela engemihle zengeza inani, uSharan waphawula.Izikhuthazi zomgogodla zibiza isilinganiso esingu-$16,957 ngoJanuwari 2015, ekhuphuke ngo-8% kusukela ngonyaka odlule, ngokusho kwe-Modern Healthcare/ECRI Institute Technology Price Index.Amamodeli amasha, ayinkimbinkimbi kakhulu akhiqizwa i-Boston Scientific and Medtronic abiza isilinganiso sama-$19,000, kusukela cishe ku-$13,000 kumamodeli amadala, umbukiso wedatha we-ECRI.
Izibhedlela zikhetha amamodeli amasha, kubika i-ECRI, nakuba izibuyekezo ezinjengokuxhumeka kwe-Bluetooth zingenzi lutho ukuthuthukisa ukukhululeka kobuhlungu, ngokusho kukaSharan.Umongameli womphakathi uthe ufaka imishini engaba ngu-300 ngonyaka, okuhlanganisa ne-SCS, futhi uzama ukwenza "umehluko omkhulu, lapho ngikhuluma nodokotela, mayelana nezici nomsebenzi. Abantu bayalahleka ngempela kumathuluzi amasha acwebezelayo."
Isikhathi sokuthumela: Jan-27-2017